Samsung Biologics to Acquire PolyPeptide via CHF 1.46 Billion Public Tender Offer

Marco Zingaro Europe Legal Chronicle
Tagged:

Homburger has advised PolyPeptide Group AG. Lenz & Staehelin has advised Draupnir Holding B.V., PolyPeptide’s largest shareholder. Samsung Biologics has launched an all-cash public tender offer…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here